On Tuesday, Travelers Companies Inc (NYSE:TRV)’s shares inclined 1.66% to $100.93.
The Travelers Companies, Inc. (NYSE: TRV) will review its third quarter 2015 results at 9 a.m. ET on Tuesday, October 20, following the release of results earlier that morning.
The Travelers Companies, Inc., through its auxiliaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the Unites states and internationally. It operates in three segments: Business and International Insurance; Bond & Specialty Insurance; and Personal Insurance.
Intersil Corp (NASDAQ:ISIL)’s shares gained 2.63% to $10.94.
Intersil Corporation (ISIL), declared financial results for the second quarter of 2015. Revenue of $132.4 million was down 1.3% sequentially. Strong gross margin and lower operating expenses resulted in solid operating margin for the eighth successive quarter. The company stated GAAP earnings per share of $0.28 and non-GAAP earnings per share of $0.16.
Company Highlights
- Gross margin performance was strong at 59.3% on a GAAP basis and 59.6% on a non-GAAP basis.
- The company again stated solid profitability, with GAAP operating margin of 12.2% and non-GAAP operating margin of 20.3%.
- Cash and cash equivalents raised to $225 million.
- New products introduced during the quarter represent industry firsts for power administration in tablets and ultrabooks, wearables and industrial applications.
Intersil Corporation designs and develops power administration and precision analog integrated circuits (ICs) for industrial and infrastructure, consumer, and computing markets. The company offers various power IC solutions for battery administration, processor power administration, and display power administration, counting power regulators, converters, and controllers, in addition to integrated power modules.
At the end of Tuesday’s trade, Allergan PLC (NYSE:AGN)‘s shares surged 2.70% to $303.95.
Allergan plc (AGN) a leading global pharmaceutical company, recently declared that Brent Saunders, CEO and President of Allergan, will provide an overview and update of the Company’s business at the Morgan Stanley Global Healthcare Conference 2015 in New York, NY.
The presentation will take place on Thursday, September 17, 2015 at 10:35 AM Eastern Time at the Grand Hyatt New York, 109 East 42nd Street, New York, NY 10017.
Allergan plc develops, manufactures, and distributes generic, branded, biosimilar, and over-the-counter (OTC) pharmaceutical products. It operates in three segments: North American Brands, North American Generics and International, and Anda Distribution. The North American Brands segment provides patented and off-patent trademarked pharmaceutical products primarily under the Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo Loestrin Fe, and Minastrin 24 Fe brands.
Cerner Corporation (NASDAQ:CERN), ended its Tuesday’s trading session with 1.44% gain, and closed at $62.64.
Cerner, have declared a contract to integrate CoverMyMeds’ ePA within Cerner’s Millennium(R) EHR. The advanced functionality will provide more than 350,000 e-prescribing end users the ability to accelerate the prescription review process by removing manual processes and assist reduce transaction costs.
According to a 2012 study by the Center for Health Transformation, PA and other medication formulary requirements are noteworthy contributors to the cost of provider interaction with health plans, which exceeds $100 billion annually. The study also showed beyond the health care costs, PA requests can delay patient treatment and result in prescription abandonment.
Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
